What is the market capitalization of Longeveron Inc.?

Longeveron Inc. (LGVN) has a market capitalization of approximately 24,119,158 USD.

Where can I buy LGVN in Canada?

LGVN can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

LGVN

Longeveron Inc.

Longeveron Inc. (LGVN) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 24 million USD (micro-cap).

Details

Price0.80 USD

Market cap24.12 M USD

Payout ratio0.00%

ROE-135.18%

Debt / Equity4.67%

SectorHealthcare

Websitelongeveron.com

Updated a few minutes ago

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.